Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1974 Mar;50(581):166–171.

Oxymetholone in aplastic anaemia

M A Mir, I W Delamore
PMCID: PMC2495533

Abstract

Thirty-one patients with aplastic anaemia were treated with oxymetholone. Twenty-eight patients lived beyond 2 months and of these eleven patients showed clinical and haematological improvement. Ten of these had some active erythropoietic areas as shown by bone marrow biopsies and by the presence of an elevated reticulocyte count in the peripheral blood. Two patients who responded in spite of a markedly hypoplastic marrow and reticulocytopenia became oxymetholone dependent and relapsed when the drug was withdrawn. They failed to respond a second time when oxymetholone was re-introduced. Side effects were frequent. These were mostly tolerable and reversible on reduction of the dose but three patients died of acute myeloblastic leukaemia and in three others the drug had to be withdrawn.

Full text

PDF
166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexanian R., Nadell J., Alfrey C. Oxymetholone treatment for the anemia of bone marrow failure. Blood. 1972 Sep;40(3):353–365. [PubMed] [Google Scholar]
  2. Allen D. M., Fine M. H., Necheles T. F., Dameshek W. Oxymetholone therapy in aplastic anemia. Blood. 1968 Jul;32(1):83–89. [PubMed] [Google Scholar]
  3. Delamore I. W., Geary C. G. Aplastic anaemia, acute myeloblastic leukaemia, and oxymetholone. Br Med J. 1971 Jun 26;2(5764):743–745. doi: 10.1136/bmj.2.5764.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hervé L., Daiber A., Con I., Donoso A. Treatment of aplastic anemia with nandrolone decanoate. Blood. 1970 Dec;36(6):748–753. [PubMed] [Google Scholar]
  5. ISRAELS M. C., WILKINSON J. F. Idiopathic aplastic anaemia. Incidence and management. Lancet. 1961 Jan 14;1(7168):63–65. doi: 10.1016/s0140-6736(61)92115-8. [DOI] [PubMed] [Google Scholar]
  6. LEWIS S. M. COURSE AND PROGNOSIS IN APLASTIC ANAEMIA. Br Med J. 1965 Apr 17;1(5441):1027–1031. doi: 10.1136/bmj.1.5441.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MOHLER D. N., LEAVELL B. S. Aplastic anemia: an analysis of 50 cases. Ann Intern Med. 1958 Aug;49(2):326–362. doi: 10.7326/0003-4819-49-2-326. [DOI] [PubMed] [Google Scholar]
  8. McCredie K. B. Oxymetholone in refractory anaemia. Br J Haematol. 1969 Sep;17(3):265–273. doi: 10.1111/j.1365-2141.1969.tb01372.x. [DOI] [PubMed] [Google Scholar]
  9. Reynafarje C., Faura J. Erythrokinetics in the treatment of aplastic anemia with methandrostenolone. Arch Intern Med. 1967 Dec;120(6):654–660. [PubMed] [Google Scholar]
  10. SANCHEZ-MEDAL L., PIZZUTO J., TORRE-LOPEZ E., DERBEZ R. EFFECT OF OXYMETHOLONE IN REFRACTORY ANEMIA. Arch Intern Med. 1964 May;113:721–729. doi: 10.1001/archinte.1964.00280110101020. [DOI] [PubMed] [Google Scholar]
  11. SCOTT J. L., CARTWRIGHT G. E., WINTROBE M. M. Acquired aplastic anemia: an analysis of thirty-nine cases and review of the pertinent literature. Medicine (Baltimore) 1959 May;38(2):119–172. [PubMed] [Google Scholar]
  12. SHAHIDI N. T., DIAMOND L. K. Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases. N Engl J Med. 1961 May 11;264:953–967. doi: 10.1056/NEJM196105112641901. [DOI] [PubMed] [Google Scholar]
  13. Sanchez-Medal L., Gomez-Leal A., Duarte L., Guadalupe Rico M. Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood. 1969 Sep;34(3):283–300. [PubMed] [Google Scholar]
  14. Silink S. J., Firkin B. G. An analysis of hypoplastic anaemia with special reference to the use of oxymetholone ("Adroyd") in its therapy. Australas Ann Med. 1968 Aug;17(3):224–235. doi: 10.1111/imj.1968.17.3.224. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES